A prospective cohort to assess patient's tolerability for endoscopic therapy of Barrett's esphagus

The Post-Procedural pain after Endoscopic Therapy for Barrett's esohagus cohort: a continuous, prospective registration on patient's tolerability.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26070

Enrollment

200

Registered

2017-12-17

Start date

2016-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's Esophagus, Barrett's neoplasia, endoscopic treatment, endoscopic ablation, RFA, cryoablation, endoscopic resection, EMR, ESD

Interventions

Patients receive a 14 days digital diary to assess retrosternal pain (range 0-10), dysphagia (range 0-4) and use of analgesics (yes/no, type).

Eligibility

Inclusion criteria

Inclusion criteria: All patients (all age, both sexes) undergoing endoscopic therapy for Barrett's esophagus, that consent to complete a 14-days digital diary post-procedure

Exclusion criteria

Exclusion criteria: No access to e-mail

Design outcomes

Primary

Measure	Time frame
Cumulative pain through 14 days, defined as the area under the curve for a pain versus time (14 days) plot	—

Secondary

Measure	Time frame
Cumulative dysphagia, cumulative use of analgesics, peak pain score, duration of pain	—

Contacts

Public ContactS.N. van Munster

AMC

s.n.vanmunster@amc.uva.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)